Thanks for the clarification, I missed that. Still, I don't trust Adam. He's been spot on with a few biotechs over the years, but his MO is to bash away without merit. He's been severly wrong on quite a few huge biotechs this year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.